Heat shock protein 70: Roles in multiple sclerosis

Molecular Medicine

Volumn 18, Issue , 2012, Pages 1018-1028

  Mansilla, María José ^a   Montalban, Xavier ^a   Espejo, Carmen ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; HEAT SHOCK COGNATE PROTEIN 70; HEAT SHOCK PROTEIN 70;

CELL LOSS; CELLULAR IMMUNITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENETIC ANALYSIS; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; ISCHEMIC PRECONDITIONING; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; NERVE CELL; NERVE POTENTIAL; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN MISFOLDING; REVIEW; THERAPY EFFECT; ANIMAL; BIOLOGICAL MODEL; CELL PROTECTION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; CYTOPROTECTION; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOMODULATION; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; NEURONS;

EID: 84873289305     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2012.00119     Document Type: Review

References (157)

1. Flynn GC, Chappell TG, Rothman JE. (1989) Peptide binding and release by proteins implicated as catalysts of protein assembly. Science. 245:385–90.
2. Beckmann RP, Mizzen LE, Welch WJ. (1990) Interaction of Hsp 70 with newly synthesized proteins: implications for protein folding and assembly. Science. 248:850–4.
3. Hartl FU, Hayer-Hartl M. (2002) Molecular chaperones in the cytosol: from nascent chain to folded protein. Science. 295:1852–8.
4. Murakami H, Pain D, Blobel G. (1988) 70-kD heat shock-related protein is one of at least two distinct cytosolic factors stimulating protein import into mitochondria. J. Cell Biol. 107:2051–7.
5. Shi Y, Thomas JO. (1992) The transport of proteins into the nucleus requires the 70-kilodalton heat shock protein or its cytosolic cognate. Mol. Cell. Biol. 12:2186–92.
6. Ritossa FA. (1962) New puffing pattern induced by temperature shock and DNP in Drosophila. Experentia. 18:571–3.
7. Li GC, Werb Z. (1982) Correlation between synthesis of heat shock proteins and development of thermotolerance in Chinese hamster fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 79:3218–22.
8. Riabowol KT, Mizzen LA, Welch WJ. (1988) Heat shock is lethal to fibroblasts microinjected with antibodies against hsp70. Science. 242:433–6.
9. Lindquist S, Craig EA. (1988) The heat-shock proteins. Annu. Rev. Genet. 22:631–77.
10. Welch WJ. (1993) Heat shock proteins functioning as molecular chaperones: their roles in normal and stressed cells. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 339:327–33.
11. Jaattela M. (1999) Heat shock proteins as cellular lifeguards. Ann. Med. 31:261–71.
12. Hunt C, Morimoto RI. (1985) Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70. Proc. Natl. Acad. Sci. U. S. A. 82:6455–9.
13. Tavaria M, Gabriele T, Kola I, Anderson RL. (1996) A hitchhiker’s guide to the human Hsp70 family. Cell Stress Chaperones. 1:23–8.
14. Daugaard M, Rohde M, Jaattela M. (2007) The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions. FEBS Lett. 581:3702–10.
15. Sospedra M, Martin R. (2005) Immunology of multiple sclerosis. Annu. Rev. Immunol. 23:683–747.
16. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. (2000) Multiple sclerosis. N. Engl. J. Med. 343:938–52.
17. Rajaiah R, Moudgil KD. (2009) Heat-shock proteins can promote as well as regulate autoimmunity. Autoimmun. Rev. 8:388–93.
18. van Eden W, van der Zee R, Prakken B. (2005) Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat. Rev. Immunol. 5:318–30.
19. Tytell M, Hooper PL. (2001) Heat shock proteins: new keys to the development of cytoprotective therapies. Expert Opin. Ther. Targets. 5:267–87.
20. Turturici G, Sconzo G, Geraci F. (2011) Hsp70 and its molecular role in nervous system diseases. Biochem. Res. Int. 2011:618127.
21. National MS Society. About MS: who gets MS [Internet]? [cited 2012 Aug 27]. Available from: http://www.nationalmssociety.org/aboutmultiple-sclerosis/what-weknow-about-ms/who-gets-ms/index.aspx
22. Compston A, Coles A. (2002) Multiple sclerosis. Lancet. 359:1221–31.
23. Whitacre CC. (2001) Sex differences in autoimmune disease. Nat. Immunol. 2:777–80.
24. Sundstrom P, et al. (2004) An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology. 62:2277–82.
25. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 296:2832–8.
26. Smolders J, Damoiseaux J, Menheere P, Hupperts R. (2008) Vitamin D as an immune modulator in multiple sclerosis, a review. J. Neuroimmunol. 194:7–17.
27. Handel AE, et al. (2011) Smoking and multiple sclerosis: an updated meta-analysis. PLoS One. 6:e16149.
28. Dyment DA, Ebers GC, Sadovnick AD. (2004) Genetics of multiple sclerosis. Lancet Neurol. 3:104–10.
29. Hafler DA, et al. (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357:851–62.
30. Frohman EM, Racke MK, Raine CS. (2006) Multiple sclerosis—the plaque and its pathogenesis. N. Engl. J. Med. 354:942–55.
31. Zamvil SS, Steinman L. (1990) The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:579–621.
32. Pettinelli CB, McFarlin DE. (1981) Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. J. Immunol. 127:1420–3.
33. Mokhtarian F, McFarlin DE, Raine CS. (1984) Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature. 309:356–8.
34. van der Veen RC, Trotter JL, Clark HB, Kapp JA. (1989) The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein. J. Neuroimmunol. 21:183–91.
35. Wucherpfennig KW, Strominger JL. (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:695–705.
36. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199:971–9.
37. Dore-Duffy P, Washington R, Dragovic L. (1993) Expression of endothelial cell activation antigens in microvessels from patients with multiple sclerosis. Adv. Exp. Med. Biol. 331:243–8.
38. Comabella M, Khoury SJ. (2012) Immunopatho-genesis of multiple sclerosis. Clin. Immunol. 142:2–8.
39. Morimoto RI. (1998) Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes. Dev. 12:3788–96.
40. Mayer MP, Bukau B. (2005) Hsp70 chaperones: cellular functions and molecular mechanism. Cell. Mol. Life Sci. 62:670–84.
41. Voellmy R, Boellmann F. (2007) Chaperone regulation of the heat shock protein response. Adv. Exp. Med. Biol. 594:89–99.
42. Freedman MS, Buu NN, Ruijs TC, Williams K, Antel JP. (1992) Differential expression of heat shock proteins by human glial cells. J. Neuroimmunol. 41:231–8.
43. Satoh J, Yamamura T, Kunishita T, Tabira T. (1992) Heterogeneous induction of 72-kDa heat shock protein (HSP72) in cultured mouse oligodendrocytes and astrocytes. Brain Res. 573:37–43.
44. Satoh J, Kim SU. (1994) HSP72 induction by heat stress in human neurons and glial cells in culture. Brain Res. 653:243–50.
45. Foster JA, Brown IR. (1997) Differential induction of heat shock mRNA in oligodendrocytes, microglia, and astrocytes following hyperthermia. Brain Res. Mo Brain Res. l. 45:207–18.
46. Mosser DD, Morimoto RI. (2004) Molecular chaperones and the stress of oncogenesis. Oncogene. 23:2907–18.
47. Benn SC, Woolf CJ. (2004) Adult neuron survival strategies—slamming on the brakes. Nat. Rev. Neurosci. 5:686–700.
48. Beere HM. (2004) “The stress of dying”: the role of heat shock proteins in the regulation of apoptosis. J. Cell Sci. 117:2641–51.
49. Lanneau D, de Thonel A, Maurel S, Didelot C, Garrido C. (2007) Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27. Prion. 1:53–60.
50. Evans CG, Wisen S, Gestwicki JE. (2006) Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1–42) aggregation in vitro. J. Biol. Chem. 281:33182–91.
51. Magrane J, Smith RC, Walsh K, Querfurth HW. (2004) Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons. J. Neurosci. 24:1700–6.
52. Dou F, et al. (2003) Chaperones increase association of tau protein with microtubules. Proc. Natl. Acad. Sci. U. S. A. 100:721–6.
53. Muchowski PJ, et al. (2000) Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglut-amine proteins into amyloid-like fibrils. Proc. Natl. Acad. Sci. U. S. A. 97:7841–6.
54. Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM. (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson’s disease. Science. 295:865–8.
55. Heneka MT, et al. (2001) The heat shock response reduces myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in mice. J. Neurochem. 77:568–79.
56. Zhang JF, Huang R, Xu J, Jin SJ, Yang YJ. (2007) Protective effects of heat shock preconditioning on the experimental autoimmune encephalomyelitis rats [in Chinese]. Zhongguo Dang Dai Er Ke Za Zhi. 9:563–6.
57. Brown IR. (1991) Expression of heat shock genes (hsp70) in the mammalian nervous system. Results Probl. Cell Differ. 17:217–29.
58. Tytell M, Greenberg SG, Lasek RJ. (1986) Heat shock-like protein is transferred from glia to axon. Brain Res. 363:161–4.
59. Hightower LE, Guidon PT Jr. (1989) Selective release from cultured mammalian cells of heat-shock (stress) proteins that resemble glia-axon transfer proteins. J. Cell Physiol. 138:257–66.
60. Sheller RA, Smyers ME, Grossfeld RM, Ballinger ML, Bittner GD. (1998) Heat-shock proteins in axoplasm: high constitutive levels and transfer of inducible isoforms from glia. J. Comp. Neurol. 396:1–11.
61. Guzhova I, et al. (2001) In vitro studies show that Hsp70 can be released by glia and that exogenous Hsp70 can enhance neuronal stress tolerance. Brain Res. 914:66–73.
62. Gao YL, Brosnan CF, Raine CS. (1995) Experimental autoimmune encephalomyelitis. Qualitative and semiquantitative differences in heat shock protein 60 expression in the central nervous system. J. Immunol. 154:3548–56.
63. Aquino DA, Klipfel AA, Brosnan CF, Norton WT. (1993) The 70-kDa heat shock cognate protein (HSC70) is a major constituent of the central nervous system and is up-regulated only at the mRNA level in acute experimental autoimmune encephalomyelitis. J. Neurochem. 61:1340–8.
64. Aquino DA, et al. (1997) Multiple sclerosis: altered expression of 70- and 27-kDa heat shock proteins in lesions and myelin. J. Neuropathol. Exp. Neurol. 56:664–72.
65. Chabas D, et al. (2001) The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 294:1731–5.
66. Rajdev S, et al. (2000) Mice overexpressing rat heat shock protein 70 are protected against cerebral infarction. Ann. Neurol. 47:782–91.
67. Hoehn B, et al. (2001) Overexpression of HSP72 after induction of experimental stroke protects neurons from ischemic damage. J. Cereb. Blood Flow Metab. 21:1303–9.
68. Stadelmann C, et al. (2005) Tissue preconditioning may explain concentric lesions in Balo’s type of multiple sclerosis. Brain. 128:979–87.
69. Brosnan CF, Battistini L, Gao YL, Raine CS, Aquino DA. (1996) Heat shock proteins and multiple sclerosis: a review. J. Neuropathol. Exp. Neurol. 55:389–402.
70. Bajramovic JJ, et al. (2000) Differential expression of stress proteins in human adult astrocytes in response to cytokines. J. Neuroimmunol. 106:14–22.
71. D’Souza SD, Antel JP, Freedman MS. (1994) Cy-tokine induction of heat shock protein expression in human oligodendrocytes: an interleukin-1-mediated mechanism. J. Neuroimmunol. 50:17–24.
72. Fleshner M, Johnson JD. (2005) Endogenous extra-cellular heat shock protein 72: releasing signal(s) and function. Int. J. Hyperthermia. 21:457–71.
73. Binder RJ, Vatner R, Srivastava P. (2004) The heat-shock protein receptors: some answers and more questions. Tissue Antigens. 64:442–51.
74. Calderwood SK, Mambula SS, Gray PJ Jr. (2007) Extracellular heat shock proteins in cell signaling and immunity. Ann. N. Y. Acad. Sci. 1113:28–39.
75. Van Eden W, Wick G, Albani S, Cohen I. (2007) Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases. Ann. N. Y. Acad. Sci. 1113:217–37.
76. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. (2000) Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 12:1539–46.
77. Hunter-Lavin C, et al. (2004) Hsp70 release from peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 324:511–7.
78. Clayton A, Turkes A, Navabi H, Mason MD, Tabi Z. (2005) Induction of heat shock proteins in B-cell exosomes. J. Cell Sci. 118:3631–8.
79. Lancaster GI, et al. (2004) Exercise induces the release of heat shock protein 72 from the human brain in vivo. Cell Stress Chaperones. 9:276–80.
80. Bausero MA, Gastpar R, Multhoff G, Asea A. (2005) Alternative mechanism by which IFN-gamma enhances tumor recognition: active release of heat shock protein 72. J. Immunol. 175:2900–12.
81. Asea A, et al. (2002) Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277:15028–34.
82. Multhoff G, et al. (1999) Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells. Exp. Hematol. 27:1627–36.
83. Gross C, et al. (2003) Heat shock protein 70-reac-tivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells. Cell Stress Chaperones. 8:348–60.
84. Gastpar R, et al. (2005) Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res. 65:5238–47.
85. Asea A, et al. (2000) HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6:435–42.
86. Moroi Y, et al. (2000) Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70. Proc. Natl. Acad. Sci. U. S. A. 97:3485–90.
87. Lehner T, et al. (2000) Heat shock proteins generate beta-chemokines which function as innate adjuvants enhancing adaptive immunity. Eur. J. Immunol. 30:594–603.
88. Panjwani NN, Popova L, Srivastava PK. (2002) Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. J. Immunol. 168:2997–3003.
89. Singh-Jasuja H, et al. (2000) The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur. J. Immunol. 30:2211–5.
90. Kuppner MC, et al. (2001) The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors. Eur. J. Immunol. 31:1602–9.
91. Becker T, Hartl FU, Wieland F. (2002) CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J. Cell Biol. 158:1277–85.
92. Suto R, Srivastava PK. (1995) A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science. 269:1585–8.
93. Doody AD, et al. (2004) Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function. J. Immunol. 172:6087–92.
94. Li Y, Subjeck J, Yang G, Repasky E, Wang XY. (2006) Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy. Vaccine. 24:5360–70.
95. Gong J, et al. (2010) A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical use. J. Immunol. 184:488–96.
96. Bausinger H, et al. (2002) Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur. J. Immunol. 32:3708–13.
97. Gao B, Tsan MF. (2003) Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J. Biol. Chem. 278:174–9.
98. Cwiklinska H, et al. (2003) Heat shock protein 70 associations with myelin basic protein and proteolipid protein in multiple sclerosis brains. Int. Immunol. 15:241–9.
99. Mycko MP, et al. (2004) Inducible heat shock protein 70 promotes myelin autoantigen presentation by the HLA class II. J. Immunol. 172:202–13.
100. Lund BT, et al. (2006) Association of MBP peptides with Hsp70 in normal appearing human white matter. J. Neurol. Sci. 249:122–34.
101. Galazka G, et al. (2006) Brain-derived heat shock protein 70-peptide complexes induce NK cell-dependent tolerance to experimental autoimmune encephalomyelitis. J. Immunol. 176:1588–99.
102. Galazka G, et al. (2007) EAE tolerance induction with Hsp70-peptide complexes depends on H60 and NKG2D activity. J. Immunol. 179:4503–12.
103. Mycko MP, et al. (2008) A heat shock protein gene (Hsp70.1) is critically involved in the generation of the immune response to myelin antigen. Eur. J. Immunol. 38:1999–2013.
104. Battistini L, et al. (1995) Gamma delta T cell receptor analysis supports a role for HSP 70 selection of lymphocytes in multiple sclerosis lesions. Mol. Med. 1:554–62.
105. Freedman MS, Ruijs TC, Selin LK, Antel JP. (1991) Peripheral blood gamma-delta T cells lyse fresh human brain-derived oligodendrocytes. Ann. Neurol. 30:794–800.
106. Lockhart E, Green AM, Flynn JL. (2006) IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177:4662–9.
107. Sutton CE, et al. (2009) Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity. 31:331–41.
108. Rachitskaya AV, et al. (2008) Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J. Immunol. 180:5167–71.
109. Cwiklinska H, Mycko MP, Szymanska B, Matysiak M, Selmaj KW. (2010) Aberrant stress-induced Hsp70 expression in immune cells in multiple sclerosis. J. Neurosci. Res. 88:3102–10.
110. Routsias JG, Tzioufas AG. (2006) The role of chaperone proteins in autoimmunity. Ann. N. Y. Acad. Sci. 1088:52–64.
111. Lamb JR, et al. (1989) Stress proteins may provide a link between the immune response to infection and autoimmunity. Int. Immunol. 1:191–6.
112. Munk ME, et al. (1989) T lymphocytes from healthy individuals with specificity to self-epitopes shared by the mycobacterial and human 65-kilodalton heat shock protein. J. Immunol. 143:2844–9.
113. Abulafia-Lapid R, et al. (1999) T cell prolifera-tive responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. J. Autoimmun. 12:121–9.
114. Perschinka H, et al. (2003) Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23:1060–5.
115. Res PC, et al. (1988) Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobac-teria in early chronic arthritis. Lancet. 2:478–80.
116. Salvetti M, et al. (1992) T-lymphocyte reactivity to the recombinant mycobacterial 65- and 70-kDa heat shock proteins in multiple sclerosis. J. Autoimmun. 5:691–702.
117. Salvetti M, et al. (1996) The immune response to mycobacterial 70-kDa heat shock proteins frequently involves autoreactive T cells and is quantitatively disregulated in multiple sclerosis. J. Neuroimmunol. 65:143–53.
118. Stinissen P, et al. (1995) Increased frequency of gamma delta T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements. J. Immunol. 154:4883–94.
119. Chiba S, et al. (2006) Autoantibodies against HSP70 family proteins were detected in the cerebrospinal fluid from patients with multiple sclerosis. J. Neurol. Sci. 241:39–43.
120. Jorgensen C, Gedon E, Jaquet C, Sany J. (1998) Gastric administration of recombinant 65 kDa heat shock protein delays the severity of type II collagen induced arthritis in mice. J. Rheumatol. 25:763–7.
121. Wendling U, et al. (2000) A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue. J. Immunol. 164:2711–7.
122. Chandawarkar RY, Wagh MS, Kovalchin JT, Srivastava P. (2004) Immune modulation with high-dose heat-shock protein gp96: therapy of murine autoimmune diabetes and encephalomyelitis. Int. Immunol. 16:615–24.
123. Birnbaum G, et al. (1998) Heat shock proteins and experimental autoimmune encephalomyelitis. II: environmental infection and extra-neuraxial inflammation alter the course of chronic relapsing encephalomyelitis. J. Neuroimmunol. 90:149–61.
124. Raz I, et al. (2001) Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet. 358:1749–53.
125. Wieten L, et al. (2009) IL-10 is critically involved in mycobacterial HSP70 induced suppression of proteoglycan-induced arthritis. PLoS One. 4:e4186.
126. Pockley AG, Shepherd J, Corton JM. (1998) Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals. Immunol. Invest. 27:367–77.
127. Pockley AG, Bulmer J, Hanks BM, Wright BH. (1999) Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals. Cell Stress Chaperones. 4:29–35.
128. Pockley AG, Muthana M, Calderwood SK. (2008) The dual immunoregulatory roles of stress proteins. Trends Biochem. Sci. 33:71–9.
129. Wright BH, Corton JM, El-Nahas AM, Wood RF, Pockley AG. (2000) Elevated levels of circulating heat shock protein 70 (Hsp70) in peripheral and renal vascular disease. Heart Vessels. 15:18–22.
130. Pockley AG, et al. (2000) Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension. 36:303–7.
131. Pockley AG, Georgiades A, Thulin T, de Faire U, Frostegard J. (2003) Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension. 42:235–8.
132. Birnbaum G, Kotilinek L. (1997) Heat shock or stress proteins and their role as autoantigens in multiple sclerosis. Ann. N. Y. Acad. Sci. 835:157–67.
133. Bustamante MF, et al. (2011) Implication of the Toll-like receptor 4 pathway in the response to interferon-beta in multiple sclerosis. Ann. Neurol. 70:634–45.
134. Yokota S, Chiba S, Furuyama H, Fujii N. (2010) Cerebrospinal fluids containing anti-HSP70 autoantibodies from multiple sclerosis patients augment HSP70-induced proinflammatory cytokine production in monocytic cells. J. Neuroimmunol. 218:129–33.
135. Milner CM, Campbell RD. (1990) Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics. 32:242–51.
136. Favatier F, Bornman L, Hightower LE, Gunther E, Polla BS. (1997) Variation in hsp gene expression and Hsp polymorphism: do they contribute to differential disease susceptibility and stress tolerance? Cell Stress Chaperones. 2:141–55.
137. Wu B, Hunt C, Morimoto R. (1985) Structure and expression of the human gene encoding major heat shock protein HSP70. Mol. Cell. Biol. 5:330–41.
138. Ramachandran S, Bell RB. (1995) Heat shock protein 70 gene polymorphisms and multiple sclerosis. Tissue Antigens. 46:140–1.
139. Cascino I, et al. (1994) HSP70–1 promoter region polymorphism tested in three autoimmune diseases. Immunogenetics. 39:291–3.
140. Niino M, et al. (2001) Heat shock protein 70 gene polymorphism in Japanese patients with multiple sclerosis. Tissue Antigens. 58:93–6.
141. Satoh J, et al. (2005) Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol. Dis. 18:537–50.
142. Mandel M, Gurevich M, Pauzner R, Kaminski N, Achiron A. (2004) Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus. Clin. Exp. Immunol. 138:164–70.
143. Bomprezzi R, et al. (2003) Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum. Mol. Genet. 12:2191–9.
144. Cudkowicz ME, et al. (2008) Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis. Muscle Nerve. 38:837–44.
145. Traynor BJ, et al. (2006) Neuroprotective agents for clinical trials in ALS: a systematic assessment. Neurology. 67:20–7.
146. Benn SC, Brown RH Jr. (2004) Putting the heat on ALS. Nat. Med. 10:345–7.
147. Kieran D, et al. (2004) Treatment with arimoclo-mol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat. Med. 10:402–5.
148. Dello Russo C, et al. (2006) The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J. Neurochem. 99:1351–62.
149. Jurivich DA, Sistonen L, Kroes RA, Morimoto RI. (1992) Effect of sodium salicylate on the human heat shock response. Science. 255:1243–5.
150. Ohtsuka K, Kawashima D, Gu Y, Saito K. (2005) Inducers and co-inducers of molecular chaperones. Int. J. Hyperthermia. 21:703–11.
151. Eriksen JL, et al. (2003) NSAIDs and enan-tiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J. Clin. Invest. 112:440–9.
152. Fu YF, et al. (2006) (5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide derivative, prevents experimental autoimmune encephalomyelitis via inhibiting T cell activation. J. Neuroimmunol. 175:142–51.
153. Wang Y, Mei Y, Feng D, Xu L. (2008) Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J. Neurosci. Res. 86:2441–9.
154. Kizelsztein P, Komarnytsky S, Raskin I. (2009) Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-kappaB/IkappaBalpha transcriptional complex. J. Neuroimmunol. 217:28–37.
155. Liu Q, et al. (2004) Triptolide (PG-490) induces apoptosis of dendritic cells through sequential p38 MAP kinase phosphorylation and caspase 3 activation. Biochem. Biophys. Res. Commun. 319:980–6.
156. Westerheide SD, Kawahara TL, Orton K, Morimoto RI. (2006) Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J. Biol. Chem. 281:9616–22.
157. Liu Q. (2011) Triptolide and its expanding multiple pharmacological functions. Int. Im-munopharmacol. 11:377–83.